Quantcast

Latest Clinical Laboratory Improvement Amendments Stories

2010-08-16 05:00:00

ANN ARBOR, Mich., Aug. 16 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN) announced today its second quarter 2010 financial results and recent achievements. Adeona will hold a conference call on Monday, August 16, at 10:00 a.m. EDT to discuss these results. James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer, will host the call. In order to participate, please call toll free: 1-800-860-2442 (US); international dial-in: 1-412-858-4600; Canadian toll free:...

2010-08-05 14:00:00

DENVER, Aug. 5 /PRNewswire/ -- Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug and alcohol abuse, has announced the expansion of its oral fluid testing capabilities. The company is the first lab in the nation to develop an analytical test capable of detecting Ethyl Sulfate (EtS) in saliva, a chemical produced by the body after alcohol exposure. Forensic Laboratories' new test method will also simultaneously detect Ethyl Glucuronide (EtG)....

2010-08-03 08:50:00

BALTIMORE, Aug. 3 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received "Moderate Complexity" status from the U.S. Food and Drug Administration, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAX(TM) GBS Assay for Group B Streptococcus (GBS) on the BD MAX(TM) System. With the "Moderate Complexity" categorization, the BD MAX GBS Assay will increase access to cost effective...

2010-07-26 07:00:00

MORRISVILLE, N.C., July 26 /PRNewswire/ -- Gentris Corporation, a global leader in applied clinical pharmacogenomics, announced today that they have appointed Karen Weck, M.D., as a consulting Medical Director. Dr. Weck replaces the previous medical director to continue Gentris' CLIA program and help expand opportunities to develop new biomarkers. "Gentris is very fortunate to have Dr. Weck join us as a consulting Medical Director," said Dawn Bordeaux, Chief Operating Officer of Gentris....

2010-06-24 09:20:00

LOUISVILLE, Ky., June 24/PRNewswire/ -- PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. (GH). The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine." "The affiliation with Generation Health takes our company, and the reality...

2010-06-23 12:56:00

RICHMOND, Va., June 23 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.), www.myhdl.com, a leader in disease state management, today announced its new capability to run the CYP2C19 genetic test. HDL, Inc., headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile. "Cytochrome P450 2C19 (CYP2C19) enzyme is involved in the liver's...

2010-05-06 15:03:00

SAN DIEGO, May 6 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today reported its financial results for the first quarter ended March 31, 2010. (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) First Quarter Results Total revenue for the first quarter of 2010 grew 22% to $10.6 million, compared with $8.7 million for the first quarter of 2009. The increase in revenue was due to higher systems and consumables sales over the same period last year. Net loss for the...

2010-04-28 10:00:00

DENVER, April 28 /PRNewswire/ -- Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has been named one of 50 Colorado Companies to Watch for 2010. Colorado Companies to Watch is hosted by the Colorado Office of Economic Development and International Trade in partnership with the Edward Lowe Foundation. The award recognizes second-stage companies that are developing valuable products and services, creating jobs, enriching communities, and...

2010-03-31 15:09:00

In the news release, FDA grants CLIA-waived status to CoaguChek XS Plus system for PT/INR testing at the point of care, issued yesterday by Roche Diagnostics, Inc. over PR Newswire, we are advised by the company that the third paragraph, second sentence was submitted to read "In addition, recent enhancements to the system include the ability to hold up to 1000 patient results and the reduction of the sample size requirement to 8 microliters" rather than "8 ml" as published by PR Newswire....

2010-03-30 16:51:00

INDIANAPOLIS, March 30 /PRNewswire/ -- Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing. The waiver means that the monitoring technology may now be used in a broader range of clinical settings, such as labs...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related